QQ客服 官方微博 反馈留言

	COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR
	Lu Renquan[1]; Hu Xiaobo[2]; Zhou Junmei[3]; Sun Jiajun[4]; Zhu Alan Z[5]; Xu Xiaofeng[6]; Zheng Hui[7]; Gao Xiang[8]; Wang Xian[9]; Jin Hongchuan[10]
刊名	Nature communications
	2016
卷号	7页码:12044
ISSN号	2041-1723
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2236273
专题	上海大学
作者单位	1.[1]Department of Clinical Laboratory, Shanghai Cancer Center, Fudan University 2.Department of Oncology, Shanghai Medical School, Fudan University, Shanghai 200032, China. 3.[2]Department of Laboratory Medicine, Long Hua Hospital, Shanghai University of TCM, Shanghai 200032, China. 4.[3]Gerchi Biotech Research Laboratories, 100 Research Park, Zhejiang 314300, China. 5.[4]Department of Clinical Laboratory, Shanghai Cancer Center, Fudan University 6.Department of Oncology, Shanghai Medical School, Fudan University, Shanghai 200032, China. 7.[5]Gerchi Biotech Research Laboratories, 100 Research Park, Zhejiang 314300, China. 8.[6]Department of Clinical Laboratory, Shanghai Cancer Center, Fudan University 9.Department of Oncology, Shanghai Medical School, Fudan University, Shanghai 200032, China. 10.[7]Department of Clinical Laboratory, Shanghai Cancer Center, Fudan University
推荐引用方式 GB/T 7714	Lu Renquan[1],Hu Xiaobo[2],Zhou Junmei[3],et al. COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR[J]. Nature communications,2016,7:12044.
APA	Lu Renquan[1].,Hu Xiaobo[2].,Zhou Junmei[3].,Sun Jiajun[4].,Zhu Alan Z[5].,...&Guo Lin[12].(2016).COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.Nature communications,7,12044.
MLA	Lu Renquan[1],et al."COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR".Nature communications 7(2016):12044.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。